Article
Study of the pharmacokinetic and pharmacogenetic contribution to the toxicity of high-dose methotrexate in children with acute lymphoblastic leukemia.
Medical oncology (Northwood, London, England) - 1 Sept 2012
El-Khodary Noha M, El-Haggar Sahar M, Eid Manal A, Ebeid Emad N
Abstract excerpt
Methotrexate inhibits the conversion of 5,10-methylenetetrahydrofolate to 5-methyltetrahydrofolate by methylenetetrahydrofolate reductase (MTHFR). MTHFR has a common functional polymorphism C677T. The present study aimed to investigate the prevalence of MTHFR polymorphisms in Egyptian children with ALL and the relation to MTX-related toxicity, relapse, and MTX pharmacokinetic parameters. Forty patients with ALL...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
